- Company Overview for ASHINGTON LINTONVILLE LIMITED (15650916)
- Filing history for ASHINGTON LINTONVILLE LIMITED (15650916)
- People for ASHINGTON LINTONVILLE LIMITED (15650916)
- More for ASHINGTON LINTONVILLE LIMITED (15650916)
| Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
|---|---|---|---|
| 08 May 2026 | CS01 | Confirmation statement made on 15 April 2026 with updates | |
| 30 Apr 2026 | AA01 | Previous accounting period shortened from 30 April 2026 to 31 March 2026 | |
| 12 Dec 2025 | AA | Accounts for a dormant company made up to 30 April 2025 | |
| 08 Dec 2025 | AP01 | Appointment of Dr Andrew David Bell as a director on 1 December 2025 | |
| 08 Dec 2025 | AD01 | Registered office address changed from 30 Bowes Street Blyth NE24 1BD United Kingdom to Lintonville Medical Group Lintonville Terrace Ashington Northumberland NE63 9UT on 8 December 2025 | |
| 08 Dec 2025 | AP01 | Appointment of Dr Lindsay John Gilfillan as a director on 1 December 2025 | |
| 05 Dec 2025 | TM01 | Termination of appointment of Harpreet Singh Kullar as a director on 1 December 2025 | |
| 05 Dec 2025 | PSC07 | Cessation of Harpreet Singh Kullar as a person with significant control on 1 December 2025 | |
| 05 Dec 2025 | PSC02 | Notification of Ashington Central Limited as a person with significant control on 1 December 2025 | |
| 05 Dec 2025 | AP01 | Appointment of Mr Rakesh Chopra as a director on 1 December 2025 | |
| 05 Dec 2025 | AP01 | Appointment of Mr Sukhpreet Singh Kullar as a director on 1 December 2025 | |
| 29 Apr 2025 | CS01 | Confirmation statement made on 15 April 2025 with no updates | |
| 16 Apr 2024 | NEWINC |
Incorporation
Statement of capital on 2024-04-16
|